189 related articles for article (PubMed ID: 19275612)
1. Chalcones in cancer: understanding their role in terms of QSAR.
Katsori AM; Hadjipavlou-Litina D
Curr Med Chem; 2009; 16(9):1062-81. PubMed ID: 19275612
[TBL] [Abstract][Full Text] [Related]
2. Chalcones in cancer: understanding their role in terms of QSAR. II part.
Repanas A; Katsori AM; Hadjipavlou-Litina D
Mini Rev Med Chem; 2013 Jun; 13(7):952-70. PubMed ID: 22876949
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and QSAR study of 2'-hydroxy-4'-alkoxy chalcone derivatives that exert cytotoxic activity by the mitochondrial apoptotic pathway.
Marquina S; Maldonado-Santiago M; Sánchez-Carranza JN; Antúnez-Mojica M; González-Maya L; Razo-Hernández RS; Alvarez L
Bioorg Med Chem; 2019 Jan; 27(1):43-54. PubMed ID: 30482548
[TBL] [Abstract][Full Text] [Related]
4. Lipoxygenase inhibitors: a comparative QSAR study review and evaluation of new QSARs.
Pontiki E; Hadjipavlou-Litina D
Med Res Rev; 2008 Jan; 28(1):39-117. PubMed ID: 17191217
[TBL] [Abstract][Full Text] [Related]
5. Chalcones derivatives acting as cell cycle blockers: potential anti cancer drugs?
Boumendjel A; Ronot X; Boutonnat J
Curr Drug Targets; 2009 Apr; 10(4):363-71. PubMed ID: 19355861
[TBL] [Abstract][Full Text] [Related]
6. Chalcone inhibits the proliferation of human breast cancer cell by blocking cell cycle progression and inducing apoptosis.
Hsu YL; Kuo PL; Tzeng WS; Lin CC
Food Chem Toxicol; 2006 May; 44(5):704-13. PubMed ID: 16307839
[TBL] [Abstract][Full Text] [Related]
7. Methoxy- and fluoro-chalcone derivatives arrest cell cycle progression and induce apoptosis in human melanoma cell A375.
Henmi K; Hiwatashi Y; Hikita E; Toyama N; Hirano T
Biol Pharm Bull; 2009 Jun; 32(6):1109-13. PubMed ID: 19483325
[TBL] [Abstract][Full Text] [Related]
8. QSAR of Chalcones Utilizing Theoretical Molecular Descriptors.
Nandi S; Bagchi MC
Curr Comput Aided Drug Des; 2015; 11(2):184-93. PubMed ID: 26135340
[TBL] [Abstract][Full Text] [Related]
9. Studies of structure-activity relationship on plant polyphenol-induced suppression of human liver cancer cells.
Loa J; Chow P; Zhang K
Cancer Chemother Pharmacol; 2009 May; 63(6):1007-16. PubMed ID: 18766342
[TBL] [Abstract][Full Text] [Related]
10. Chalcones with electron-withdrawing and electron-donating substituents: anticancer activity against TRAIL resistant cancer cells, structure-activity relationship analysis and regulation of apoptotic proteins.
Mai CW; Yaeghoobi M; Abd-Rahman N; Kang YB; Pichika MR
Eur J Med Chem; 2014 Apr; 77():378-87. PubMed ID: 24675137
[TBL] [Abstract][Full Text] [Related]
11. Anti-tumor activity of SL4 against breast cancer cells: induction of G
Wang LH; Jiang XR; Chen GL; Guo W; Zhang JY; Cui LJ; Li HH; Li M; Liu X; Yang JY; Wu CF
Sci Rep; 2016 Nov; 6():36486. PubMed ID: 27819344
[TBL] [Abstract][Full Text] [Related]
12. Novel synthetic chalcones induce apoptosis in the A549 non-small cell lung cancer cells harboring a KRAS mutation.
Wang Y; Hedblom A; Koerner SK; Li M; Jernigan FE; Wegiel B; Sun L
Bioorg Med Chem Lett; 2016 Dec; 26(23):5703-5706. PubMed ID: 27810244
[TBL] [Abstract][Full Text] [Related]
13. Induction of apoptosis and cell cycle arrest in L-1210 murine lymphoblastic leukaemia cells by (2E)-3-(2-naphthyl)-1-(3'-methoxy-4'-hydroxy-phenyl)-2-propen-1-one.
Pedrini FS; Chiaradia LD; Licínio MA; de Moraes AC; Curta JC; Costa A; Mascarello A; Creczinsky-Pasa TB; Nunes RJ; Yunes RA; Santos-Silva MC
J Pharm Pharmacol; 2010 Sep; 62(9):1128-36. PubMed ID: 20796191
[TBL] [Abstract][Full Text] [Related]
14. Heterocyclic chalcone analogues as potential anticancer agents.
Sharma V; Kumar V; Kumar P
Anticancer Agents Med Chem; 2013 Mar; 13(3):422-32. PubMed ID: 22721390
[TBL] [Abstract][Full Text] [Related]
15. Antiproliferative activity and p53 upregulation effects of chalcones on human breast cancer cells.
Dos Santos MB; Bertholin Anselmo D; de Oliveira JG; Jardim-Perassi BV; Alves Monteiro D; Silva G; Gomes E; Lucia Fachin A; Marins M; de Campos Zuccari DAP; Octavio Regasini L
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1093-1099. PubMed ID: 31117836
[TBL] [Abstract][Full Text] [Related]
16. Recent progress in therapeutic applications of chalcones.
Katsori AM; Hadjipavlou-Litina D
Expert Opin Ther Pat; 2011 Oct; 21(10):1575-96. PubMed ID: 21711087
[TBL] [Abstract][Full Text] [Related]
17. Superior anticancer activity of halogenated chalcones and flavonols over the natural flavonol quercetin.
Dias TA; Duarte CL; Lima CF; Proença MF; Pereira-Wilson C
Eur J Med Chem; 2013 Jul; 65():500-10. PubMed ID: 23771043
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxicity, molecular modeling, cell cycle arrest, and apoptotic induction induced by novel tetrahydro-[1,2,4]triazolo[3,4-a]isoquinoline chalcones.
Mohamed MF; Hassaneen HM; Abdelhamid IA
Eur J Med Chem; 2018 Jan; 143():532-541. PubMed ID: 29207336
[TBL] [Abstract][Full Text] [Related]
19. Involvement of extrinsic and intrinsic apoptotic pathways together with endoplasmic reticulum stress in cell death induced by naphthylchalcones in a leukemic cell line: advantages of multi-target action.
Winter E; Chiaradia LD; Silva AH; Nunes RJ; Yunes RA; Creczynski-Pasa TB
Toxicol In Vitro; 2014 Aug; 28(5):769-77. PubMed ID: 24583196
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of synthesized 2'-oxygenated chalcone derivatives: modulation of human cell cycle phase distribution.
Rao YK; Fang SH; Tzeng YM
Bioorg Med Chem; 2004 May; 12(10):2679-86. PubMed ID: 15110849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
